Fund Details
UTI Focussed Equity Fund Series VI (1150 Days) Regular Growth
| Risk | Moderately High |
|---|---|
| Min SIP Amount | Not Supported |
| Expense Ratio | 1.28% |
| NAV | ₹13.17 (20 Jan 2021) |
|---|---|
| Fund Started | 12 Feb 2018 |
| Fund Size | ₹389 Cr |
Returns
Comparison
Found nothing so far.
Found nothing so far.
Top Holdings
| Name | Sector | Instrument | % Assets |
|---|---|---|---|
| ICICI Bank Ltd. | Financial | Equity | 8.4% |
| Infosys Ltd. | Technology | Equity | 7.7% |
| Bharti Airtel Ltd. | Communication | Equity | 6.8% |
| Cipla Ltd. | Healthcare | Equity | 5.5% |
| Multi Commodity Exchange India | Financial | Equity | 5.4% |
| Eicher Motors Ltd. | Automobile | Equity | 5.1% |
| Axis Bank Ltd. | Financial | Equity | 4.9% |
| Torrent Pharmaceuticals Ltd. | Healthcare | Equity | 4.9% |
| Crompton Greaves Consumer Electricals Ltd. | Cons Durable | Equity | 4.9% |
| Ipca Laboratories Ltd. | Healthcare | Equity | 4.6% |
Fund Managers
UTI Focussed Equity Fund Series VI (1150 Days) Regular Growth Details
UTI Focussed Equity Fund Series VI (1150 Days) Regular Growth is a Equity Mutual Fund Scheme launched by UTI Mutual Fund. This scheme was made available to investors on 12 Feb 2018. Vetri Subramaniam, Sachin Trivedi is the Current Fund Manager of UTI Focussed Equity Fund Series VI (1150 Days) Regular Growth fund.The fund currently has an Asset Under Management(AUM) of ₹389 Cr and the Latest NAV as of 20 Jan 2021 is ₹13.17.
The UTI Focussed Equity Fund Series VI (1150 Days) Regular Growth is rated Moderately High risk.
Investment Objective
The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of listed companies. The scheme will without any capitalization bias endeavour to invest in either growth stocks or value stocks or both. The Scheme will normally hold upto 30 stocks in the portfolio.
